Skip to content
★ Sign in to follow
MK

Mina Kim

Directeur Juridique
Zymergen Inc.ACELYRIN, Inc.
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
23
Companies
4
▲ Purchases (1 ops.)
€82k
▼ Sales (6 ops.)
€75k

Latest filing published 23 May 2025 for ACELYRIN, Inc..

Filing timeline

BuySale
Mina Kim

Insider track record

Disclosed buys
1
Disclosed sells
6

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Mina Kim: trading record in brief

This profile gathers the share dealings of Mina Kim across 4 companies, led by ACELYRIN, Inc., Zymergen Inc. and Atara Biotherapeutics, Inc. The record holds 23 filings, for trades running from 8 November 2016 to 21 May 2025.

On the open market, the record shows 1 purchase worth €82k and 6 sales worth €75k. The net balance comes to €7,377 on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 15 share grants. 2025 to date brings no purchases and 1 sale.

On 23 May 2025 came the latest disclosure, a transaction in ACELYRIN, Inc. The last insider purchase was made public on 11 May 2023, 1,277 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Mina Kim

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ◆
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    89,526 sharesCommon StockSEC:0001962918-25-000068:0
  • ◆
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    30,851 shares0Common StockSEC:0001962918-25-000038:0
  • ▼
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    49,354 USD40SEC
    17,986 shares@ US$2.74426.8% of flowCommon StockSEC:0001962918-25-000031:0
  • ◆
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    575,000 shares0Common StockSEC:0001962918-25-000007:0
  • ◆
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    45,728 USD28SEC
    10,230 shares@ US$4.4724.8% of flowCommon StockSEC:0001962918-24-000061:0
  • ◆
    Chief Legal & Admin. OfficerExecutivesACELYRIN, Inc.
    0SEC
    114,676 shares0Common StockSEC:0001962918-23-000023:0
  • ▲
    Chief Legal & Admin. OfficerExecutivesACELYRIN, Inc.
    90,000 USD38SEC
    5,000 shares@ US$18.0048.4% of flowCommon StockSEC:0001209191-23-028870:0
    Canonical exit: 7 Aug 2023 (T+90)
  • ▼
    Chief Legal OfficerExecutivesZymergen Inc.
    7,536 USD29SEC
    3,410 shares@ US$2.2125.8% of flowCommon StockSEC:0001645842-22-000124:0
  • ▼
    Chief Legal OfficerExecutivesZymergen Inc.
    8,083 USD29SEC
    3,094 shares@ US$2.612527.1% of flowCommon StockSEC:0001645842-22-000107:0
  • ▼
    Chief Legal OfficerExecutivesZymergen Inc.
    3,866 USD24SEC
    2,924 shares@ US$1.322312.8% of flowCommon StockSEC:0001645842-22-000102:0
  • ▼
    Chief Legal OfficerExecutivesZymergen Inc.
    4,930 USD25SEC
    2,939 shares@ US$1.677615.6% of flowCommon StockSEC:0001645842-22-000100:0
  • ▼
    Chief Legal OfficerExecutivesZymergen Inc.
    5,740 USD25SEC
    3,206 shares@ US$1.790318.6% of flowCommon StockSEC:0001645842-22-000061:0
  • ◆
    Chief Legal OfficerExecutivesZymergen Inc.
    0SEC
    217,000 shares0Common StockSEC:0001645842-22-000030:0
  • ◆
    Chief Legal OfficerExecutivesZymergen Inc.
    0SEC
    97,000 shares0Common StockSEC:0001104659-21-131243:0

14 of 14 declarations